Understanding patient cost-sharing thresholds for diabetes treatment attributes via a discrete choice experiment

BACKGROUND: The process used to prefer certain products across drug classes for diabetes is generally focused on comparative effectiveness and cost. However, payers rarely tie patient preference for treatment attributes to formulary management resulting in a misalignment of value defined by provider...

Descripción completa

Detalles Bibliográficos
Autores principales: Panchal, Rupesh, Nguyen, Danielle, Ghule, Priyanka, Li, Niying, Giannouchos, Theodoros, Pan, Raymond J, Biskupiak, Joseph, Britton, Laura, Nohavec, Robert, Slager, Stacey, Ngorsuraches, Surachat, Brixner, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387929/
https://www.ncbi.nlm.nih.gov/pubmed/36705280
http://dx.doi.org/10.18553/jmcp.2023.29.2.139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387929/
https://www.ncbi.nlm.nih.gov/pubmed/36705280
http://dx.doi.org/10.18553/jmcp.2023.29.2.139

Ejemplares similares